- Home
- SBH vs EYPT Comparison
SBH vs EYPT Comparison
Compare SBH & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBH | EYPT |
|---|---|---|
| Founded | 1964 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2006 | 2005 |
Fundamental Metrics
Financial Performance| Metric | SBH | EYPT |
|---|---|---|
| Price | $12.50 | $12.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $17.25 | ★ $31.80 |
| AVG Volume (30 Days) | ★ 1.6M | 772.1K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.17 | N/A |
| EPS | ★ 0.88 | N/A |
| Revenue | ★ $3,701,424,000.00 | $7,539,000.00 |
| Revenue This Year | $2.20 | N/A |
| Revenue Next Year | $1.82 | $3,115.57 |
| P/E Ratio | $13.71 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.45 | $5.46 |
| 52 Week High | $17.92 | $19.11 |
Technical Indicators
Market Signals| Indicator | SBH | EYPT |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 42.23 |
| Support Level | N/A | $11.74 |
| Resistance Level | $15.75 | $14.73 |
| Average True Range (ATR) | 0.63 | 0.75 |
| MACD | -0.14 | -0.15 |
| Stochastic Oscillator | 34.22 | 35.37 |
Price Performance
Historical ComparisonAbout SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. The company operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, Netherlands, and other geographical regions. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. The products offered by the company include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.